Blockade of NF-κB Using IκBα Dominant-Negative Mice Ameliorates Cardiac Hypertrophy in Myotrophin-Overexpressed Transgenic Mice
- 5 September 2008
- journal article
- Published by Elsevier BV in Journal of Molecular Biology
- Vol. 381 (3), 559-568
- https://doi.org/10.1016/j.jmb.2008.05.076
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (HL63034)
- American Heart Association (0565226B)
This publication has 53 references indexed in Scilit:
- Prevention of Cardiac Hypertrophy and Heart Failure by Silencing of NF-κBJournal of Molecular Biology, 2007
- Microarray analysis of Akt1 activation in transgenic mouse hearts reveals transcript expression profiles associated with compensatory hypertrophy and failurePhysiological Genomics, 2006
- Blockade of NF-κB improves cardiac function and survival after myocardial infarctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Cardioprotection afforded by NF-κB ablation is associated with activation of Akt in mice overexpressing TNF-αAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Inhibition of NF-κB induces regression of cardiac hypertrophy, independent of blood pressure control, in spontaneously hypertensive ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Activation of nuclear factor-κB is necessary for myotrophin-induced cardiac hypertrophyThe Journal of cell biology, 2002
- Effect of NF- κ B Inhibition on TNF- α -induced Apoptosis and Downstream Pathways in CardiomyocytesJournal of Molecular and Cellular Cardiology, 2001
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart StudyNew England Journal of Medicine, 1990
- Human monocyte chemoattractant protein-1 (MCP-1)Immunology Today, 1990